Multimodal Retinal Imaging for the Detection of Early Alzheimer’s Disease: Combining Biochemical, Structural, and Vascular Biomarkers
Published in Bioengineering, 2026
This proof-of-concept study investigates whether multimodal retinal imaging—hyperspectral imaging, optical coherence tomography, and color fundus photography—can differentiate individuals with and without cerebral amyloid-beta pathology, supporting multimodal retinal imaging as a scalable, non-invasive screening approach for early Alzheimer’s disease.
Read the plain-language summary of this paper →
Recommended citation: Ghesquiere, M. et al. (2026). "Multimodal Retinal Imaging for the Detection of Early Alzheimer’s Disease: Combining Biochemical, Structural, and Vascular Biomarkers." Bioengineering 13(9):1041. doi:10.3390/bioengineering13091041.
Download Paper